Navigation Links
Mice model to study bacterial therapeutic pathway

Researchers from Flanders Interuniversity Institute for Biotechnology are finding out the mechanism behind bacterial resistance from studying certain mice which had the capacity to resist bacterial infection. // The researchers are using this mice model to find out new therapeutic pathways which could help in treating bacterial infections.

Bacterial infections are the most common infection which affects people in all age groups mostly affecting the immune compromised. There as been an increase in bacterial resistance to antibiotics which is a real cause of concern, nosocomial infections are also increased and these hospital acquired strains are the most antibiotic resistance than the normal strains.

Researcher Tina mahieu and her colleagues found that certain mice are not so sensitive as the normal mice to immune stimulus and producing increased amount of Interferon 1 immune response causing an inflammation which can cause lethal shock. They studied the mice which produced only a small amount of Interferon 1 compared to ordinary mice which still recognizes the bacterial antigens and kills them but does not lead to inflammation reaction and adverse reaction on human health. Researcher’s feels that these mice model would help in finding out the mechanism involved in immune protection in animals and would help in finding newer therapeutic approaches to combat bacterial infection.


'"/>




Page: 1

Related medicine news :

1. Novel computer model for breast cancer
2. MRI, To Detect Remodeling Of Heart and Help Preserve Function
3. Down syndrome simulated in animal model after successful chromosome transplantation
4. Synthetic protein found to relieve arthritis symptoms in animal model
5. Heart transplanted infants better model for developing AIDS treatment
6. Mice model becomes surrogate for human prostate
7. Stem of Hope: Stem Cell Research Acquires a Brittle Star As A model
8. Business model for Liver Institute cleared by Delhi Cabinet
9. Healthcare System Remodelled - Iraq
10. A new study surpasses Gene Therapy Hurdle
11. A question on study of Adult Stem Cell
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2017)... ... April 28, 2017 , ... An April 24th article on Yahoo! Beauty discusses ... with the help of a weight loss surgery. The woman, declaring “I will not hate ... been left following her dramatic weight loss. Dr. Feiz & Associates notes that, while it ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... its new partnership with the Home Care Association of America (HCAOA). This agreement ... Private Duty Accreditation services, as well as discounts on Accreditation University (AU) educational ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... to announce the integration of Microsoft(R) Word(TM) Online(TM), which enables sleep physicians to ... since it streamlines the reporting process and provides a familiar interface that does ...
(Date:4/28/2017)... ... ... Horizon Blue Cross Blue Shield of New Jersey (BCBSNJ) announced today that ... as “stable.” At the same time, the ratings agency cautioned that the company’s rating ... “capital adequacy” thresholds required for its strong rating. , “Horizon is committed to being ...
(Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, Inc. announced today ... throughout the Northeast U.S. , GlycoMark is the only clinically available blood ... provides a clinically proven one- to two-week measure of hyperglycemic excursions, often related ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017  Cogentix Medical, Inc. (NASDAQ: ... providing the Urology, Uro/Gyn and Gynecology markets with ... Keswani has joined the Company as Senior Vice ... created position, Mr. Keswani will report directly to ... "Our organization is delighted that Ash has ...
(Date:4/20/2017)...  RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage ... unmet medical needs, today announced that it will ... development program, based on its proprietary self-delivering RNAi ... (SID) 76 th Annual Meeting.  The SID ... relevant to skin health and disease through education, ...
(Date:4/20/2017)... April 20, 2017  AbbVie (NYSE: ABBV), a ... (n=145/146) of chronic hepatitis C virus (HCV) infected ... 6 and compensated cirrhosis (Child-Pugh A) achieved sustained ... ) with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir ... seen following 12 weeks of G/P treatment without ...
Breaking Medicine Technology: